Diagnosis and classification of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis: Current concepts and remaining challenges. Issue 1 (20th May 2014)
- Record Type:
- Journal Article
- Title:
- Diagnosis and classification of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis: Current concepts and remaining challenges. Issue 1 (20th May 2014)
- Main Title:
- Diagnosis and classification of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis: Current concepts and remaining challenges
- Authors:
- Hashimoto, Etsuko
Tokushige, Katsutoshi
Ludwig, Jurgen - Abstract:
- <abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <p>The high prevalence of non‐alcoholic fatty liver disease (NAFLD) has made the condition an important public health issue. Two clinical entities are manifestations of NAFLD, namely, non‐alcoholic fatty liver (NAFL) and non‐alcoholic steatohepatitis (NASH). The former tends to be benign and non‐progressive while the latter can progress to cirrhosis, which in rare cases gives rise to hepatocellular carcinoma. The diagnosis of NAFLD is based on: (i) a history of no or limited daily alcohol intake (&lt;20 g for women and &lt;30 g for men); (ii) presence of hepatic steatosis by imaging or by histology; and (iii) exclusion of other liver diseases. NAFL is defined histologically by the presence of bland, primarily macrovesicular, hepatocellular fatty change, while NASH features fatty change with inflammation and evidence of hepatocyte injury, such as ballooning degeneration. Presence of fibrosis is a sign of chronicity. Thus, the diagnosis of NAFL/NASH rests on clinicopathological criteria; it always requires both clinical and biopsy‐based information. NAFLD could be both the result and the cause of metabolic syndrome, with a vicious cycle operating between these conditions. Remaining challenges are: (i) the lack of a clear threshold alcohol intake for defining "non‐alcoholic"; (ii) a lacking consensus for the classification of fatty liver disease; and (iii) absence of a histological definition<abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <p>The high prevalence of non‐alcoholic fatty liver disease (NAFLD) has made the condition an important public health issue. Two clinical entities are manifestations of NAFLD, namely, non‐alcoholic fatty liver (NAFL) and non‐alcoholic steatohepatitis (NASH). The former tends to be benign and non‐progressive while the latter can progress to cirrhosis, which in rare cases gives rise to hepatocellular carcinoma. The diagnosis of NAFLD is based on: (i) a history of no or limited daily alcohol intake (&lt;20 g for women and &lt;30 g for men); (ii) presence of hepatic steatosis by imaging or by histology; and (iii) exclusion of other liver diseases. NAFL is defined histologically by the presence of bland, primarily macrovesicular, hepatocellular fatty change, while NASH features fatty change with inflammation and evidence of hepatocyte injury, such as ballooning degeneration. Presence of fibrosis is a sign of chronicity. Thus, the diagnosis of NAFL/NASH rests on clinicopathological criteria; it always requires both clinical and biopsy‐based information. NAFLD could be both the result and the cause of metabolic syndrome, with a vicious cycle operating between these conditions. Remaining challenges are: (i) the lack of a clear threshold alcohol intake for defining "non‐alcoholic"; (ii) a lacking consensus for the classification of fatty liver disease; and (iii) absence of a histological definition of NASH, which currently remains the gold standard for the diagnosis. Further challenges include the overlap of the criteria for NAFLD and alcoholic liver disease as many obese individuals also consume considerable volumes of alcohol.</p> </abstract> … (more)
- Is Part Of:
- Hepatology research. Volume 45:Issue 1(2015:Jan.)
- Journal:
- Hepatology research
- Issue:
- Volume 45:Issue 1(2015:Jan.)
- Issue Display:
- Volume 45, Issue 1 (2015)
- Year:
- 2015
- Volume:
- 45
- Issue:
- 1
- Issue Sort Value:
- 2015-0045-0001-0000
- Page Start:
- 20
- Page End:
- 28
- Publication Date:
- 2014-05-20
- Subjects:
- Liver -- Diseases -- Periodicals
Liver Diseases -- Periodicals
Foie -- Maladies -- Périodiques
616.362 - Journal URLs:
- http://www.sciencedirect.com/science/journal/09284346 ↗
http://firstsearch.oclc.org/journal=1386-6346;screen=info;ECOIP ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1872-034X ↗
http://www.sciencedirect.com/science/journal/13866346 ↗
http://www3.interscience.wiley.com/journal/118507311/home ↗
http://www.blackwell-synergy.com/rd.asp?goto=journal&code=hep ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/hepr.12333 ↗
- Languages:
- English
- ISSNs:
- 1386-6346
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4295.845000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3038.xml